The latest myeloma treatment advances from ASCO 2023

The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6 in Chicago! Clinicians and researchers gathered to present and discuss several updates in multiple myeloma relating to: Chimeric antigen receptor (CAR) T-cell therapies, Bispecific antibodies (also known as T-cell engagers) in combination or as monotherapy, Treatment for newly diagnosed disease, and Maintenance therapy. Let us break down the key findings for you…

Link: https://themmrf.org/2023/06/08/the-latest-myeloma-treatment-advances-from-asco-2023/